AI assistant
Indivior PLC — Board/Management Information 2018
Sep 19, 2018
4923_dirs_2018-09-19_85613f4e-f1e8-42d2-a0fa-66a7529bffda.html
Board/Management Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 3081B
Indivior PLC
19 September 2018
Indivior PLC (the 'Company')
Indivior PLC confirms that Mr Howard Pien, Non-Executive Chairman, was appointed as an independent director of Idera Pharmaceuticals, Inc., a specialty pharmaceutical company listed on the NASDAQ Stock Market, with effect from September 18, 2018.
This announcement is made in accordance with Listing Rule 9.6.14.
Kathryn Hudson
Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
RDNFKCDNQBKDPCD